AB
NVO

Atlas Brown’s Novo Nordisk NVO Stock Holding History

Atlas Brown’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$279K Buy
+7,357
New +$339K 0.07% 197
2025
Q4 		– Sell
-4,499
Closed -$250K – 231
2025
Q3 		$250K Sell
4,499
-4,526
-50% -$265K 0.07% 198
2025
Q2 		$623K Buy
9,025
+933
+12% +$63.5K 0.2% 107
2025
Q1 		$562K Buy
8,092
+2,962
+58% +$245K 0.2% 111
2024
Q4 		$441K Buy
5,130
+1,285
+33% +$139K 0.15% 133
2024
Q3 		$458K Sell
3,845
-438
-10% -$58.4K 0.16% 132
2024
Q2 		$611K Buy
4,283
+460
+12% +$61K 0.22% 108
2024
Q1 		$491K Buy
3,823
+95
+3% +$11.3K 0.18% 117
2023
Q4 		$386K Hold
3,728
– – 0.16% 128
2023
Q3 		$339K Hold
3,728
– – 0.15% 132
2023
Q2 		$302K Hold
3,728
– – 0.13% 142
2023
Q1 		$297K Buy
3,728
+8
+0.2% +$567 0.14% 139
2022
Q4 		$252K Buy
+3,720
New +$218K 0.12% 153
2022
Q3 		– Sell
-3,720
Closed -$207K – 174
2022
Q2 		$207K Hold
3,720
– – 0.1% 165
2022
Q1 		$207K Hold
3,720
– – 0.08% 180
2021
Q4 		$208K Buy
+3,720
New +$202K 0.08% 184

Other funds holding NVO

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
MCP
Martin Capital Partners Eugene, Oregon $279M AUM 18.87% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EIA
Eastover Investment Advisors Charlotte, North Carolina $257M AUM 14.8% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
NFGCM
Norman Fields Gottscho Capital Management New York $329M AUM 22.06% 1-Year Est. Return
BFA
Benedict Financial Advisors Atlanta, Georgia $504M AUM 20.67% 1-Year Est. Return
HWA
Heartwood Wealth Advisors Richmond, Virginia $1.27B AUM 11.08% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM

Atlas Brown's NVO Position: Q3 2026 in Review

Atlas Brown opened a new position in Novo Nordisk (NVO) in Q3 2026: 7,357 shares worth $279K. The stake represents 0.07% of the portfolio and ranks #197 among its holdings. This is a return to the name: Atlas Brown previously reported a position in NVO as recently as Q3 2025.

Atlas Brown first reported a position in NVO in Q4 2021 and has held it in 16 quarters since. The position peaked at $623K in Q2 2025. 64 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Atlas Brown held 7,357 shares of Novo Nordisk worth $279K as of Q3 2026.
  • Novo Nordisk was a new Atlas Brown position in Q3 2026.
  • Novo Nordisk made up 0.07% of Atlas Brown's portfolio in Q3 2026, its #197 holding.
  • Atlas Brown first reported a position in Novo Nordisk in Q4 2021 and has held it in 16 quarters since.
  • Atlas Brown's Novo Nordisk position peaked at $623K in Q2 2025.
  • 64 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Atlas Brown's 13F filing for Q3 2026, filed 9 Oct 2026.